Tag: <span>Diabetes drug</span>

Home / Diabetes drug
With trial success in kidney disease, Lilly, Boehringer make case for broader use of diabetes drug
Post

With trial success in kidney disease, Lilly, Boehringer make case for broader use of diabetes drug

Jonathan Gardner Senior Reporter Eli Lilly & Co. Dive Brief: Eli Lilly and Boehringer Ingelheim’s drug Jardiance kept clinical trial participants with kidney disease from needing dialysis or a transplant, the companies announced Wednesday, a finding that cements the diabetes pill’s potential as a treatment for a wider array of metabolic diseases. The trial was expected...

Post

Heart Disease-Protective Diabetes Drug Not Used Equitably, Study Finds

A medication typically used for treating diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RA), could also be used to prevent cardiovascular disease and major cardiovascular events, but a new study showed inequities in its use based on race, ethnicity, and socioeconomic status. Looking at four years of data, researchers from the Perelman School of Medicine at...

Common diabetes drug not effective against early-stage breast cancer, researchers say
Post

Common diabetes drug not effective against early-stage breast cancer, researchers say

by Amanda Ferguson, University of Toronto Metformin 500mg tablets. Credit: public domain A widely used and inexpensive type 2 diabetes drug, once hoped to hold enormous promise in treating breast cancer, does not prevent or stop the spread of the most common forms of the disease, according to new research. The study, which has yet...

Diabetes drug slows kidney function decline
Post

Diabetes drug slows kidney function decline

by American Society of Nephrology Credit: Pixabay/CC0 Public Domain Clinical trial data reveal that dapagliflozin— a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes—reduces the rate of kidney function decline in patients with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2021 November 4–November 7. The DAPA-CKD trial randomized 4,304...

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
Post

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

by Scott Lafee,  University of California – San Diego Metformin 500mg tablets. Credit: public domain Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans. Metformin works by lowering glucose production in...

Diabetes drug could protect against dangerous infection
Post

Diabetes drug could protect against dangerous infection

EXPERIMENTAL BIOLOGY IMAGE: METFORMIN AND C. DIFFICILE CREDIT: SHAOHUA WANG, PHD, AND HARIOM YADAV, PHD Rockville, Md. (April 27, 2021)–Researchers from Wake Forest School of Medicine in North Carolina have demonstrated that a common diabetes drug inhibits the spread of Clostridioides difficile, or C. diff–a potentially life-threatening infection commonly acquired during hospital stays. The team will...

Post

Diabetes drug shows potential in fighting cancer

MASSACHUSETTS GENERAL HOSPITAL BOSTON – The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH). In a review article in Trends in Cancer, the team presented...

Post

Nostrum expands recall of diabetes drug metformin after carcinogen concerns

Conner Mitchell Associate Editor Gener­ic met­formin has been a thorn in drug­mak­ers’ sides for months af­ter a prob­a­ble hu­man car­cino­gen was found in test­ed lots. Now, one of the com­pa­nies is ex­pand­ing its re­call to an­oth­er lot of the drug. Nos­trum Lab­o­ra­to­ries out of Kansas City, MO vol­un­tar­i­ly re­called one lot of met­formin HCl ex­tend­ed re­lease...

Post

Diabetes drug can treat and reverse heart failure and reduce

THE MOUNT SINAI HOSPITAL / MOUNT SINAI SCHOOL OF MEDICINE Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.  Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading...

Novel diabetes drug candidate shows promising properties in human islets and mouse models
Post

Novel diabetes drug candidate shows promising properties in human islets and mouse models

The drug candidate is a non-toxic small molecule that given orally effectively rescued mice from models of Type 1 and Type 2 diabetes UNIVERSITY OF ALABAMA AT BIRMINGHAM ANATH SHALEV FROM UNIVERSITY OF ALABAMA AT BIRMINGHAM view more CREDIT: UAB BIRMINGHAM, Ala. – The University of Alabama at Birmingham and Southern Research have discovered a...